alpha 1-Antitrypsin Deficiency
"alpha 1-Antitrypsin Deficiency" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Deficiency of the protease inhibitor ALPHA 1-ANTITRYPSIN that manifests primarily as PULMONARY EMPHYSEMA and LIVER CIRRHOSIS.
Descriptor ID |
D019896
|
MeSH Number(s) |
C06.552.074 C08.381.112 C16.320.060 C23.550.325.500.500
|
Concept/Terms |
alpha 1-Antitrypsin Deficiency- alpha 1-Antitrypsin Deficiency
- Deficiencies, alpha 1-Antitrypsin
- Deficiency, alpha 1-Antitrypsin
- alpha 1 Antitrypsin Deficiency
- alpha 1-Antitrypsin Deficiencies
|
Below are MeSH descriptors whose meaning is more general than "alpha 1-Antitrypsin Deficiency".
Below are MeSH descriptors whose meaning is more specific than "alpha 1-Antitrypsin Deficiency".
This graph shows the total number of publications written about "alpha 1-Antitrypsin Deficiency" by people in this website by year, and whether "alpha 1-Antitrypsin Deficiency" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2004 | 0 | 1 | 1 |
2010 | 1 | 0 | 1 |
2017 | 18 | 0 | 18 |
2018 | 11 | 0 | 11 |
2019 | 5 | 2 | 7 |
2020 | 1 | 0 | 1 |
2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "alpha 1-Antitrypsin Deficiency" by people in Profiles.
-
Insights into the potential role of alpha1-antitrypsin in COVID-19 patients: Mechanisms, current update, and future perspectives. Clin Respir J. 2021 Sep; 15(9):1019-1024.
-
COVID-19 vaccination in patients with a1-antitrypsin deficiency. Lancet Respir Med. 2021 08; 9(8):818-820.
-
Pulmonary Abnormalities in Liver Disease: Relevance to Transplantation and Outcome. Hepatology. 2021 09; 74(3):1674-1686.
-
SARS-CoV-2 infection in alpha1-antitrypsin deficiency. Respir Med. 2021 08; 184:106466.
-
COVID-19 infection in severe Alpha 1-antitrypsin deficiency: Looking for a rationale. Respir Med. 2021 07; 183:106440.
-
Alpha-1 antitrypsin deficiency severity and the risk of COVID-19: A Portuguese cohort. Respir Med. 2021 05; 181:106387.
-
Association of alpha-1-antitrypsin deficiency with vitamin D status: who is most at risk of getting severe COVID-19? Inflamm Res. 2021 Apr; 70(4):375-377.
-
a1-Antitrypsin deficiency and the risk of COVID-19: an urgent call to action. Lancet Respir Med. 2021 04; 9(4):337-339.
-
Host genomics of COVID-19: Evidence point towards Alpha 1 antitrypsin deficiency as a putative risk factor for higher mortality rate. Med Hypotheses. 2021 Feb; 147:110485.
-
An auspicious triumph of recovery from dialysis-requiring acute kidney injury in COVID-19 in a patient with chronic kidney disease, a-1 antitrypsin deficiency, and liver transplant: A case report. Clin Nephrol. 2020 Dec; 94(6):297-306.